000 01283 a2200349 4500
005 20250516181722.0
264 0 _c20140926
008 201409s 0 0 eng d
022 _a1873-2496
024 7 _a10.1016/j.urolonc.2013.08.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLamb, Benjamin W
245 0 0 _aSecond-line chemotherapy for advanced bladder cancer: a survey of current UK practice.
_h[electronic resource]
260 _bUrologic oncology
_cJan 2014
300 _a52.e11-7 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aData Collection
_xmethods
650 0 4 _aDrug Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aPractice Patterns, Physicians'
650 0 4 _aUnited Kingdom
650 0 4 _aUrinary Bladder Neoplasms
_xdrug therapy
700 1 _aVasdev, Nikhil
700 1 _aJalil, Rozh T
700 1 _aMcMenemin, Rhona
700 1 _aHughes, Simon
700 1 _aPayne, Heather
700 1 _aGreen, James S A
773 0 _tUrologic oncology
_gvol. 32
_gno. 1
_gp. 52.e11-7
856 4 0 _uhttps://doi.org/10.1016/j.urolonc.2013.08.008
_zAvailable from publisher's website
999 _c23273250
_d23273250